BLOGS >

Voices

RSS
Engage with independent insights, opinions, and analysis from an array of leaders in cardiology.
Avatar of Peter B Berger, MD

Can Bivalirudin Stand the HEAT? (14 Jul 2014)

Peter B Berger, MD

Harlan Krumholz interviews Peter Berger, an editorialist for the HEAT-PPCI study, about the paper’s findings.

Avatar of Harlan M. Krumholz, MD, SM

Poor Retention of Guideline Recommendations (14 Jul 2014)

Harlan M. Krumholz, MD, SM

Harlan Krumholz discusses a JAMA study that found a substantial proportion of Class I guideline recommendations were not durable over a 10-year period.

Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: July 14th (14 Jul 2014)

Richard Lehman, BM, BCh, MRCGP

This week’s topics are leucocyte telomere length and the risk for CVD, and the association between alcohol and CVD.

Avatar of Richard A. Lange, MD, MBA

Do FFR and IVUS Feed the Elephant? (11 Jul 2014)

Richard A. Lange, MD, MBA and L. David Hillis, MD

Rick Lange and David Hillis wonder whether the debate about the role of FFR and IVUS in patient selection for PCI is a red herring in the larger issue of revascularization in patients with stable CAD.

Avatar of Colleen

Behind the Patient Decision-Making Process for a Destination-Therapy LVAD (10 Jul 2014)

Colleen Kelley McIlvennan, DNP, ANP, Larry Allen, MD, MHS, and Dan Matlock, MD, MPH

Colleen K. McIlvennan, Larry A. Allen, and Daniel D. Matlock discuss their study of how patients choose whether to get a left ventricular assist device as destination therapy.

Avatar of David

Should Doctors Be Paid Overtime for Taking Call? (10 Jul 2014)

David Mann, MD

On call is the worst thing about being a doctor, and here’s why.

Avatar of Ben

Statins Are a Mess: We Need Better Data, and Shared Decision Making (7 Jul 2014)

Ben Goldacre, MB, BS, BA, MA, MBBS, MSc

The following open letter was originally published on The British Medical Journal‘s editorial page regarding the adverse effects of statins for patients with low risk of cardiovascular disease. It was written in response to an analysis by Abramson et al, and more information on the subject can be found here. I have two observations to make on the statin wars. Firstly: if there is any uncertainty at all about the risks and benefits of statins – and there is – then we have failed to competently implement the most basic… Continue Reading

Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: July 7th (7 Jul 2014)

Richard Lehman, BM, BCh, MRCGP

This week’s topics include the effect of patients’ risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes, a meta-analysis of revascularization vs. medical treatment in patients with stable CAD, and more.

Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: June 30th (30 Jun 2014)

Richard Lehman, BM, BCh, MRCGP

This week’s topics include atrial fibrillation and cryptogenic stroke, higher potency statins and the risk for new diabetes, and more.

Avatar of Ethan J Weiss, M.D.

Unethical Health Screening: When Unnecessary Tests Do More Harm Than Good (23 Jun 2014)

Ethan J Weiss, M.D.

Ethan Weiss discusses how unnecessary cardiovascular screening can lead to serious consequences.